The global landscape on the access to cancer medicines for breast cancer: the ONCOLLEGE experience
Hussain, Sadaqat
Hussain, Sadaqat
Abstract
There is a growing global debate over barriers affecting the timely access to innovative anticancer therapies. Access to medicines is often traced back to the issue of costs: however, more commonly, the distance between valuable innovative treatments and the actual treatment of patients is far beyond the mere problem of financial barriers. A comprehensive approach to understand, assess to medicines should be pursued, to dissect the determinants and formulate solutions for all patients. In this chapter, we discuss drivers of access to innovation for patients with breast cancer, based on a case study of access to HER2-diagnositcs and therapeutics yielding a global landscape analysis, based on the efforts and expertise of the global collaborative group "ONCOLLEGE".
MIDER Authors
Citations
Altmetric:
Date
2023
Type
Article
Subject
Access, Breast cancer, Global oncology, ONCOLLEGE-001
Collections
Citation
Lengyel, C. G., Habeeb, B. S., Altuna, S. C., Trapani, D., Khan, S. Z., & Hussain, S. (2023). The Global Landscape on the Access to Cancer Medicines for Breast Cancer: The ONCOLLEGE Experience. Cancer treatment and research, 188, 353–368. https://doi.org/10.1007/978-3-031-33602-7_14